SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Huller Kelly

(Last)

(First)

(Middle)

VALLEY FORGE BUSINESS CENTER

2560 GENERAL ARMISTEAD AVENUE

(Street)

AUDUBON

19403

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/27/2019

3. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	15,384	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy Class A Common Stock)	⁽¹⁾	06/16/2020	Class A Common Stock	3,076	$11.86	D
Stock Option (Right to Buy Class A Common Stock)	⁽²⁾	02/11/2021	Class A Common Stock	23,076	$11.28	D
Stock Option (Right to Buy Class A Common Stock)	⁽³⁾	08/29/2022	Class A Common Stock	2,500	$15.34	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁴⁾	01/30/2023	Class A Common Stock	7,500	$12.59	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁵⁾	03/04/2024	Class A Common Stock	7,500	$24.9	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁶⁾	04/01/2025	Class A Common Stock	7,500	$25.8	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁷⁾	02/02/2026	Class A Common Stock	7,500	$24.21	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁸⁾	02/02/2027	Class A Common Stock	7,500	$25.96	D
Stock Option (Right to Buy Class A Common Stock)	⁽⁹⁾	02/02/2028	Class A Common Stock	10,000	$45.64	D
Stock Option (Right to Buy Class A Common Stock)	⁽¹⁰⁾	01/22/2029	Class A Common Stock	40,000	$43.58	D

Explanation of Responses:

1. These options were granted on June 16, 2010 and are fully vested.

2. These options were granted on February 11, 2011 and are fully vested.

3. These options were granted on August 29, 2012 and are fully vested.

4. These options were granted on January 30, 2013 and are fully vested.

5. These options were granted on March 4, 2014 and are fully vested.

6. These options were granted on April 1, 2015 and are fully vested.

7. These options were granted on February 2, 2016, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

8. These options were granted on February 2, 2017, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

9. These options were granted on February 2, 2018, and vest over a four-year period with one-fourth(1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

10. These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Remarks:

	/s/ Kelly G. Huller	03/06/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.